# Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement

> **NIH NIH UL1** · UNIVERSITY OF COLORADO DENVER · 2021 · $145,763

## Abstract

Principal Investigator (Last, first, middle): Sokol, Ronald (Diversity Candidate: McNeal, Demetria, M)
SUMMARY
Abstract of NCATS-Funded UL1 Project
Funded by NIH in 2008, 2013 and 2018 the Colorado Clinical and Translational Sciences Institute (CCTSI) at
the University of Colorado Anschutz Medical Campus (CUAMC) has transformed and improved the biomedical;
research and training enterprise in the Colorado region and accelerated and catalyzed the translation of
discoveries into improved patient care and public health. The CCTSI, a partnership of CUAMC, CU Boulder,
Colorado State University, six hospitals and 20 community organizations, has established new infrastructure,
streamlined processes and expanded existing resources and services for investigators and stakeholders;
tripled the number of training and education programs supporting development of a translational workforce;
promoted team science and interdisciplinary research; established an extensive community engagement
program; created an academic home for clinical & translational scientists and trainees; and actively engaged in
CTSA network activities. CCTSI has five overall strategic goals:
Goal 1: Develop, educate and sustain a diverse translational science workforce to ensure the highest research
innovation, quality and safety.
Goal 2: Create a translational research environment in which team science and local and national collaboration
are facilitated, supported and valued.
Goal 3: Engage local and national communities and stakeholders in all phases of the translational research
process.
Goal 4: Create novel methodologies and resources to support and integrate research in special populations,
including children, the elderly, the underserved and those with rare diseases.
Goal 5: Further innovate and streamline our processes and enhance our informatics capacity for research
start-up, implementation and oversight to promote quality, efficiency, & safety of our research and our active
participation in the national CTSA Trial Innovation Network.
Dr. McNeal's proposal capitalizes on CCTSI's goals one and four and their accompanying resources in the
following ways. First, to support attainment of CCTSI goal 1, the CCTSI has established new programs and
offers resources designed to support the development of early stage career faculty. Existing programs and
resources create the ideal environment for Dr. McNeal, a junior and minority faculty member, to advance and
thrive as an independent scholar. To prepare for this submission, Dr. McNeal has already participated in one
CCTSI sponsored program (CCTSI Research Studio) in which a team of interdisciplinary senior scholars
reviewed this project proposal and provided feedback to further refine the research question and methodology.
Dr. McNeal has been competitively selected to participate in two research and career development programs:
The National Institutes of Health Programs to Increase Diversity Among Individuals Engaged in Health-Related
Resear...

## Key facts

- **NIH application ID:** 10288971
- **Project number:** 3UL1TR002535-04S1
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** RONALD J. SOKOL
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $145,763
- **Award type:** 3
- **Project period:** 2018-05-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10288971

## Citation

> US National Institutes of Health, RePORTER application 10288971, Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement (3UL1TR002535-04S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10288971. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*